易普利姆玛
无容量
医学
黑色素瘤
肿瘤科
内科学
免疫疗法
癌症研究
癌症
作者
Jedd D. Wolchok,Vanna Chiarion‐Sileni,Piotr Rutkowski,C. Lance Cowey,Dirk Schadendorf,John Wagstaff,Paola Queirolo,Reinhard Dummer,Marcus O. Butler,Andrew Hill,Michael A. Postow,Caroline Gaudy‐Marqueste,Theresa Medina,Christopher D. Lao,John R. Walker,Iván Marquez‐Rodas,John B.A.G. Haanen,Massimo Guidoboni,Michele Maio,Patrick Schöffski
标识
DOI：10.1056/nejmoa2407417
摘要
Previous results from this trial showed longer overall survival after treatment with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab monotherapy in patients with advanced melanoma. Given that patients with advanced melanoma are living longer than 7.5 years, longer-term data were needed to address new clinically relevant questions.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
不配.
pcr163
淡淡的南风
zcl
tuanheqi
子车茗
风清扬
Xiaoxiao
朝阳区李知恩
star
GingerF
eric888
Dean
无极微光
Hilda007
小青椒
聪慧的正豪
laber
从容芮
带头大哥
Criminology34
彭于彦祖
LaTeXer
殷勤的紫槐
昏睡的蟠桃
丘比特
唐泽雪穗
皖公网安备34019202002308
